Hong Kong REITS Stock News

SEHK:1288
SEHK:1288Banks

A Look At Agricultural Bank Of China’s Valuation After Strong Multi Year Shareholder Returns

Why Agricultural Bank of China Stock Is On Investors’ Radar Agricultural Bank of China (SEHK:1288) has recently drawn attention after a period of strong total returns, with the stock showing double digit gains over the past year and past three years. See our latest analysis for Agricultural Bank of China. Recent trading points to momentum building, with a 16% 1 month share price return and a 38% 1 year total shareholder return coming on top of a very large 3 year total shareholder return. If...
SEHK:1300
SEHK:1300Communications

Asian Penny Stocks To Watch In April 2026

As global markets respond positively to a U.S.-Iran ceasefire, investor sentiment has improved, leading to gains across major indices. In this context, penny stocks—often representing smaller or newer companies—can still offer intriguing opportunities for growth when backed by solid financial health. Despite being considered a niche investment area today, these stocks can provide value and potential upside for those looking beyond larger firms.
SEHK:2600
SEHK:2600Metals and Mining

Assessing Chalco (SEHK:2600) Valuation After Record First Quarter 2026 Earnings Guidance

Aluminum Corporation of China (SEHK:2600) issued first quarter 2026 earnings guidance, flagging net profit of CN¥5,302 million to CN¥5,585 million and basic EPS of CN¥0.310 to CN¥0.326, both implying 50% to 58% year-on-year growth. See our latest analysis for Aluminum Corporation of China. The earnings guidance comes after a sharp re-rating, with the 1-year total shareholder return of about 3x and a more muted share price return of 0.32% year to date at HK$12.68. Recent 7-day strength...
SEHK:2186
SEHK:2186Pharmaceuticals

A Look At Luye Pharma Group (SEHK:2186) Valuation As LY03020 Enters Phase II For Schizophrenia

Luye Pharma Group (SEHK:2186) has drawn fresh attention after reporting the first patient enrollment in a Phase II trial in China for LY03020, a dual TAAR1 and 5-HT2CR agonist targeting schizophrenia. See our latest analysis for Luye Pharma Group. The LY03020 trial update comes as Luye Pharma Group’s share price sits at HK$2.89, with a 30-day share price return of 18.93% contrasting with a 90-day share price decline of 3.99%. The 1-year total shareholder return of 55.38% stands against a...
SEHK:1810
SEHK:1810Tech

Assessing Xiaomi’s Valuation As Momentum Cools After A Strong Multi Year Shareholder Return

Why Xiaomi’s stock is drawing fresh attention Xiaomi (SEHK:1810) is back on investors’ radar after recent trading left the share price lower over the past month and the past 3 months, prompting closer scrutiny of its current valuation and business mix. See our latest analysis for Xiaomi. At the latest share price of HK$30.88, Xiaomi’s recent 30 day share price return of 7.32% and year to date share price return of 23.34% contrast with a 3 year total shareholder return of 148.23%. This...
SEHK:9858
SEHK:9858Food

China Youran Dairy Group’s Valuation After Renewed Long Term Yili Agreements Through 2029

Renewed agreements with Yili Group set the context China Youran Dairy Group (SEHK:9858) has renewed long term supply and financial agreements with controlling shareholder Yili Group. These agreements lock in their commercial relationship from 2027 to 2029 and formalize ongoing raw milk and dairy product transactions. See our latest analysis for China Youran Dairy Group. The renewed Yili contracts arrive after a weaker patch for the shares, with a 30 day share price return of 5.58% and a 90...
SEHK:1088
SEHK:1088Oil and Gas

Assessing China Shenhua Energy’s Valuation As 2025 Results Dividend Proposal And 2026 Guidance Shape Expectations

China Shenhua Energy (SEHK:1088) has drawn investor attention after reporting its 2025 results, proposing a sizeable final dividend, and outlining detailed 2026 production and sales guidance alongside sector interest in anthracite market growth. See our latest analysis for China Shenhua Energy. The recent dividend proposal and 2026 guidance land at a time when the share price is HK$45.4, with recent 1 month and 7 day share price returns softer. However, a 1 year total shareholder return of...
SEHK:1072
SEHK:1072Electrical

A Look At Dongfang Electric (SEHK:1072) Valuation After Strong Results And Higher Dividend

Dongfang Electric (SEHK:1072) has drawn fresh attention after reporting full year 2025 results alongside a declared final ordinary dividend of RMB 5.3 per 10 shares, providing both earnings and income updates for shareholders. See our latest analysis for Dongfang Electric. The full year results and higher dividend have arrived against a strong backdrop, with a 90 day share price return of 60.83% and a very large 1 year total shareholder return that far outpaces the short term moves. If...
SEHK:1735
SEHK:1735Construction

A Look At Central New Energy Holding Group (SEHK:1735) Valuation After Revenue Growth But Weaker Profitability

Central New Energy Holding Group (SEHK:1735) reported full year 2025 results, with sales of HK$11,016.85 million, net income of HK$34.24 million, and earnings per share of HK$0.0081 from continuing operations. See our latest analysis for Central New Energy Holding Group. The earnings release comes after a steady run in the shares, with a 9.55% 1 month share price return and 12.30% 3 month share price return. However, the 1 year total shareholder return is still down 6.58% while the 5 year...
SEHK:1548
SEHK:1548Life Sciences

A Look At GenScript Biotech (SEHK:1548) Valuation After New DNA Data Storage Collaboration With Mimulus

Genscript Biotech (SEHK:1548) is back in focus after announcing a multi year collaboration with Mimulus Corp to industrialize DNA based data storage, targeting scalable infrastructure and substantial cost efficiencies by 2030. See our latest analysis for Genscript Biotech. The collaboration headlines come as Genscript Biotech's share price, now at HK$12.62, shows mixed momentum, with a 13.8% 1 month share price return but a 12.42% decline over 3 months. The 1 year total shareholder return...
SEHK:576
SEHK:576Infrastructure

How Investors May Respond To Zhejiang Expressway (SEHK:576) Balancing Higher Dividend With Softer Earnings

Zhejiang Expressway Co., Ltd. recently reported its full-year 2025 results, with sales rising to CNY 19.76 billion while net income eased slightly to CNY 5.32 billion, and recommended a higher dividend of CNY 0.395 per share, all subject to approval at the 2025 annual shareholders’ meeting. The combination of revenue growth, a modest earnings dip and a proposed dividend increase highlights management’s emphasis on returning cash to shareholders while operating profitability remains under...
SEHK:9926
SEHK:9926Biotechs

Assessing Akeso (SEHK:9926) Valuation After Positive Lung Cancer Data At 2026 European Lung Cancer Congress

Akeso (SEHK:9926) has come into focus after presenting new lung cancer data at the 2026 European Lung Cancer Congress. The company updated investors on cadonilimab and ivonescimab across difficult non small cell lung cancer settings. See our latest analysis for Akeso. Following the ELCC updates, Akeso's HK$137.8 share price sits on the back of a 25.05% 1 month share price return and 21.62% year to date share price return. The 1 year total shareholder return of 58.48% and 3 year total...
SEHK:598
SEHK:598Logistics

Assessing Sinotrans (SEHK:598) Valuation After 2025 Earnings, Higher Profitability And Proposed Final Dividend

Why the latest results matter for Sinotrans shareholders Sinotrans (SEHK:598) has just reported full year 2025 earnings, with revenue lower than the previous year but higher net income and earnings per share, alongside a proposed final ordinary dividend of RMB 0.155 per share. See our latest analysis for Sinotrans. The latest figures and proposed dividend come after a relatively steady share price, with Sinotrans at HK$4.99 and modest short term moves but very strong 1 year and multi year...
SEHK:363
SEHK:363Industrials

Assessing Shanghai Industrial Holdings (SEHK:363) Valuation After Weaker Earnings And Special Dividend Proposal

Earnings and dividend proposals in focus Shanghai Industrial Holdings (SEHK:363) recently reported full year 2025 results, with both revenue and net income below the prior year, while at the same time proposing a mix of ordinary and special dividends. See our latest analysis for Shanghai Industrial Holdings. Since the annual results and dividend proposals were released, the share price has edged up, with a 1-day share price return of 0.99% and a 7-day share price return of 2.16%. The 1-year...
SEHK:108
SEHK:108Real Estate

Assessing GR Life Style (SEHK:108) Valuation After Sharply Narrowed Full Year Losses

Earnings trigger: narrowing losses at GR Life Style GR Life Style (SEHK:108) has drawn attention after reporting full year 2025 results, with net loss at HK$109.63 million versus HK$918.5 million a year earlier, and basic loss per share at HK$0.0341. See our latest analysis for GR Life Style. The earnings update comes after a mixed run for the stock, with the latest share price at HK$2.8, a 1-day share price return of 4.09%, a 90-day share price return decline of 9.39%, a very large 1-year...
SEHK:688
SEHK:688Real Estate

A Look At China Overseas Land & Investment (SEHK:688) Valuation After Strong Rebound In Contracted Sales

China Overseas Land & Investment (SEHK:688) caught investor attention after reporting March contracted property sales of about RMB28.578b, up 34.8% year on year, with first quarter contracted sales up 11% to roughly RMB51.52b. See our latest analysis for China Overseas Land & Investment. Even with the strong first quarter contracted sales update, the recent 30 day share price return decline of 6.8% and year to date share price return decline of 4.48% sit alongside a 1 year total shareholder...
SEHK:1801
SEHK:1801Biotechs

Assessing Innovent Biologics (SEHK:1801) Valuation After New IBI3055 Autoimmune Preclinical Data

Innovent Biologics (SEHK:1801) shares moved in response to fresh product news after the company presented initial preclinical data for IBI3055, a tri specific anti CD19/BCMA/CD3 T cell engager for autoimmune diseases, in Boston. See our latest analysis for Innovent Biologics. The latest IBI3055 update lands after a mixed but generally positive stretch for investors, with a 30 day share price return of 9.46%, year to date share price return of 12.31%, and a 1 year total shareholder return of...
SEHK:288
SEHK:288Food

Assessing WH Group (SEHK:288) Valuation After Upstream Turnaround And Dividend Support

Why WH Group’s latest share price high matters WH Group (SEHK:288) has reached an all time share price high after an upstream turnaround linked to the US hog market upcycle, higher dividends, and a larger role for more stable downstream operations. See our latest analysis for WH Group. At a share price of HK$10.83, WH Group has built solid momentum, with a 30 day share price return of 14.0% and a 1 year total shareholder return of 82.01%, reflecting stronger sentiment around earnings...
SEHK:728
SEHK:728Telecom

How Investors Are Reacting To China Telecom (SEHK:728) After JPMorgan’s Defensive Yield Endorsement

Earlier this month, JP Morgan issued a research report naming China Telecom as one of its preferred defensive yield plays among Chinese equities, assigning the stock an Overweight rating and emphasizing its income profile in the current macro backdrop. The report’s focus on China Telecom’s resilience and dividend appeal highlights how major institutions may be viewing the company as a potential anchor for investors seeking relative stability within China’s equity market. We’ll now look at...
SEHK:317
SEHK:317Machinery

A Look At CSSC Offshore & Marine Engineering (SEHK:317) Valuation After Earnings Guidance And Dividend Proposal

CSSC Offshore & Marine Engineering (Group) (SEHK:317) has drawn fresh attention after issuing 2026 earnings guidance targeting operating income of CN¥21.218b, along with a proposed cash dividend that would distribute roughly 30.14% of annual net profit. See our latest analysis for CSSC Offshore & Marine Engineering (Group). The 7 day share price return of 7.77% at a latest share price of HK$13.87 contrasts with a 30 day share price return decline of 11.66%. However, the 1 year total...
SEHK:1398
SEHK:1398Banks

A Look At Industrial And Commercial Bank Of China’s Valuation After Tier 2 Notes And Shareholder Meeting Plans

ICBC’s new Tier 2 notes and shareholder meeting: why they matter now Industrial and Commercial Bank of China (SEHK:1398) has just completed a CNY 50b Tier 2 capital note issuance at a fixed 2% coupon and called an extraordinary shareholders’ meeting focused on audited accounts, dividends, and 2026 investment plans. See our latest analysis for Industrial and Commercial Bank of China. ICBC’s recent Tier 2 issuance and upcoming shareholder meeting come after a period where the 1 month share...
SEHK:9973
SEHK:9973Auto

Assessing Chery Automobile (SEHK:9973) Valuation After Its Recent 22.72% One Month Share Price Move

Chery Automobile stock moves after recent performance shift Chery Automobile (SEHK:9973) has caught investor attention after a recent shift in its share performance, with the stock’s past month return of 22.72% standing out compared with its movement over the past three months. See our latest analysis for Chery Automobile. The recent 22.72% 1 month share price return contrasts with a more modest 6.95% share price return year to date. This suggests momentum has picked up lately as investors...
SEHK:9660
SEHK:9660Software

Why Horizon Robotics (SEHK:9660) Is Up 8.3% After Launching a 10% Share Buyback Program

Horizon Robotics (SEHK:9660) recently began executing a shareholder‑approved buyback program that allows repurchases of up to 1.32 billion shares, or 10% of its issued share capital, funded from legally available resources under its governing rules and laws. The company expects these repurchases to lift net asset value per share and earnings per share, sharpening investor focus on its capital allocation alongside its expanding automotive AI chip portfolio. Next, we’ll examine how Horizon...